Company Cambridge Nutritional Sciences plc

Equities

ODX

GB00B1VCP282

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Cambridge Nutritional Sciences plc

EPS Revisions

Annual profits - Rate of surprise

Sector Diagnostic & Testing Substances

Market Closed - London S.E. Other stock markets 11:35:02 2024-04-22 am EDT			5-day change	1st Jan Change
3.7 ^GBX	+13.85%		+10.45%	+54.17%

Apr. 22	Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named	MT
Apr. 22	Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024	CI

Cambridge Nutritional Sciences plc is a United Kingdom-based specialist medical diagnostics company. The Company develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The Company serves healthcare professionals and the consumer directly with a focus on health and nutrition products.

Number of employees: 91

GBP in Million	2022	Weight	2023	Weight	Delta
Health and Nutrition 100.0 %	9	100.0 %	8	100.0 %	-11.63%

GBP in Million	2022	Weight	2023	Weight	Delta
Rest of Europe 30.6 %	3	30.5 %	2	30.6 %	-11.29%
Asia and the Far East 22.9 %	2	17.6 %	2	22.9 %	+14.84%
North America 15.1 %	2	20.4 %	1	15.1 %	-34.39%
United Kingdom 12.9 %	0	5.5 %	1	12.9 %	+107.45%
Africa and the Middle East 7.4 %	1	14.1 %	1	7.4 %	-53.48%
India 7.0 %	1	6.0 %	1	7.0 %	+3.12%
South/Central America 4.0 %	1	5.9 %	0	4.0 %	-39.80%

Managers	Title	Age	Since
Jag Grewal CEO	Chief Executive Officer	54	11-06-29

Members of the board	Title	Age	Since
Simon Douglas CHM	Chairman	65	21-02-10
Jag Grewal CEO	Chief Executive Officer	54	11-06-29
Jeremy Millard BRD	Director/Board Member	53	19-02-28
Carolyn Rand BRD	Director/Board Member	60	23-08-16

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	237,950,660	216,126,793 ( 90.83 %)	0	90.83 %

Name	Equities	%	Valuation
SpreadEx Ltd. 8.192 %	19,492,888	8.192 %	849 500 p
Barclays Bank Plc (Private Banking) 4.908 %	11,679,000	4.908 %	508 971 p
IG Markets Ltd. 2.144 %	5,101,974	2.144 %	222 344 p
Unicorn Asset Management Ltd. 1.555 %	3,700,000	1.555 %	161 246 p
Octopus Investments Ltd. 1.365 %	3,248,691	1.365 %	141 578 p
Artemis Investment Management (Venture Capital) 1.261 %	3,000,862	1.261 %	130 778 p
Jag Grewal 1.034 %	2,460,839	1.034 %	107 243 p
Christopher Lea 0.9119 %	2,169,904	0.9119 %	94 564 p
Jeremy Millard 0.4308 %	1,025,000	0.4308 %	44 670 p
Canaccord Genuity Asset Management Ltd. 0.3526 %	839,012	0.3526 %	36 564 p

Cambridge Nutritional Sciences Plc

Eden Research Park Henry Crabb Road, Littleport

CB6 1SE, London

http://www.omegadiagnostics.com

address Cambridge Nutritional Sciences plc(ODX)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
CAMBRIDGE NUTRITIONAL SCIENCES PLC	+54.17%	10.86M
BIOMÉRIEUX	+0.10%	12.66B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-17.03%	7.04B
LANTHEUS HOLDINGS, INC.	+1.73%	4.32B
AUTOBIO DIAGNOSTICS CO., LTD.	-2.51%	4.45B
10X GENOMICS, INC.	-50.32%	3.31B
ANDON HEALTH CO., LTD.	+6.90%	2.6B
VITROLIFE AB	-16.74%	2.01B
MYRIAD GENETICS, INC.	-3.40%	1.67B
SANSURE BIOTECH INC.	-6.24%	1.45B

Diagnostic & Testing Substances